California’s Plan for Cheaper Insulin Collides With Big Pharma’s Price Cuts

The state awarded a $50 million contract to produce less costly treatments, but moves by major suppliers might undercut the initiative before any new product emerges.

BENJAMIN RYAN
Author: BENJAMIN RYAN

Advertisements
{ "slotId": "6845006044", "unitType": "responsive", "resize": "auto" }

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.